Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Butterfly Needle Blood Collection Sets Market (2022-2027) by Application, End-User, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global Butterfly Needle Blood Collection Sets Market is estimated to be USD 184.14 Mn in 2022 and is projected to reach USD 275.74 Mn by 2027, growing at a CAGR of 8.41%. Market Dynamics
Market dynamics are forces that impact the prices and behaviors of the Global Butterfly Needle Blood Collection Sets Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors.
There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Becton, Dickinson and Company, Braun Melsungen, Cardinal Health, Terumo, etc. Countries Studied
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Ansoff Analysis
Key Topics Covered: 1 Report Description 2 Research Methodology 3 Executive Summary 4 Market Dynamics 4.1 Drivers 4.1.1 Increase in Prevalence of Chronic Diseases 4.1.2 Precise and Easy Use of Butterfly Needles Set 4.1.3 Need for ManagIng Long Term Medication and Drug Infusion 4.2 Restraints 4.2.1 Lack of Product Innovation 4.2.2 Stringent Government Regulation 4.3 Opportunities 4.3.1 Safety and Convenience Associated with Butterfly Needles 4.4 Challenges 4.4.1 Availability of Alternatives 5 Market Analysis 5.1 Regulatory Scenario 5.2 Porter's Five Forces Analysis 5.3 Impact of COVID-19 5.4 Ansoff Matrix Analysis 6 Global Butterfly Needle Blood Collection Sets Market, By Application 6.1 Introduction 6.2 Blood Transfusion 6.3 Venipuncture 6.4 IV Rehydration 6.5 Delivery of Medications 7 Global Butterfly Needle Blood Collection Sets Market, By End-User 7.1 Introduction 7.2 Hospital 7.3 Blood Bank 7.4 Others 8 Americas' Butterfly Needle Blood Collection Sets Market 8.1 Introduction 8.2 Argentina 8.3 Brazil 8.4 Canada 8.5 Chile 8.6 Colombia 8.7 Mexico 8.8 Peru 8.9 United States 8.10 Rest of Americas 9 Europe's Butterfly Needle Blood Collection Sets Market 9.1 Introduction 9.2 Austria 9.3 Belgium 9.4 Denmark 9.5 Finland 9.6 France 9.7 Germany 9.8 Italy 9.9 Netherlands 9.10 Norway 9.11 Poland 9.12 Russia 9.13 Spain 9.14 Sweden 9.15 Switzerland 9.16 United Kingdom 9.17 Rest of Europe 10 Middle East and Africa's Butterfly Needle Blood Collection Sets Market 10.1 Introduction 10.2 Egypt 10.3 Israel 10.4 Qatar 10.5 Saudi Arabia 10.6 South Africa 10.7 United Arab Emirates 10.8 Rest of MEA 11 APAC's Butterfly Needle Blood Collection Sets Market 11.1 Introduction 11.2 Australia 11.3 Bangladesh 11.4 China 11.5 India 11.6 Indonesia 11.7 Japan 11.8 Malaysia 11.9 Philippines 11.10 Singapore 11.11 South Korea 11.12 Sri Lanka 11.13 Thailand 11.14 Taiwan 11.15 Rest of Asia-Pacific 12 Competitive Landscape 12.1 Competitive Quadrant 12.2 Market Share Analysis 12.3 Strategic Initiatives 12.3.1 M&A and Investments 12.3.2 Partnerships and Collaborations 12.3.3 Product Developments and Improvements 13 Company Profiles 13.1 Becton, Dickinson and Company 13.2 Braun Melsungen 13.3 Cardinal Health 13.4 Isomed 13.5 Kawasumi Laboratories 13.6 Medline Industries 13.7 Nipro 13.8 Terumo 14 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/vgc84i
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.